Answers are grounded in this paper and cite their sources.
N-nitrosodimethylamine (NDMA) is a semi-volatile chemical molecule that the International Agency for Research on Cancer has classified as possibly carcinogenic.It can originate from industrial or natural processes related to the N-nitrosamine family and is present in several medicinal medicines, such as angiotensin II receptor blockers and ranitidine.Ranitidine's NDMA contamination resulted in regulatory measures and the drug's removal from distribution.Sensitive analytical methods such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) or gas chromatography-mass spectrometry (GC-MS) are needed to analyze NDMA levels.Humans can safely consume up to 0.96ng, or 0.32 ppm, of NDMA daily.Numerous processes, including temperature, acidity, light exposure, metal ions, and manufacturing procedures, are involved in synthesis of NDMA from ranitidine.Adverse health effects, including cancer, kidney illness, and liver damage, have been associated with NDMA exposure.Regular testing, the use of substitute ingredients, adherence to good manufacturing procedures, cooperation, and ongoing risk assessment are examples of preventive methods to prevent contamination.Since research is currently being done to discover alternative drugs and treatment techniques for illnesses related to acid reflux, the future of ranitidine is yet uncertain.The function of ranitidine in clinical practice has changed as a result of recalls and safety concerns, and its position will continue to be influenced by ongoing research and regulatory changes.In conclusion, the discovery of NDMA contamination in ranitidine has prompted serious health concerns, regulatory actions, and the investigation of substitute drugs and safety precautions.
No takes yet. Share an insight, caveat, or question.
Kale et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: